eryaspase: Clinical Trials

2 trials of eryaspase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1
Phase 21Terminated 1

Follow eryaspase: new trials by email Literature Review of eryaspase trials Research Report on eryaspase

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)
eryaspase (L-asparaginase encapsulated in red blood cells), Gemcitabine, Carboplatin - Triple Negative Breast Cancer
Phase 2 / Phase 3TerminatedERYtech Pharma272019-06-132022-08-01
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC
eryaspase, Gemcitabine plus Abraxane, Irinotecan plus 5-FU plus leucovorin - Pancreatic Adenocarcinoma
Phase 3CompletedERYtech Pharma5122018-09-152022-10-18

Conditions studied

Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

ERYtech Pharma (2)

Countries

Belgium (1)  ·  France (1)  ·  Hungary (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Manuel Hidalgo, MD, PhD (1)  ·  Pascal Hammel, MD, PhD (1)

Results publications

PMID 41187298